Efficacy and Toxicity of Combined Inhibition of EGFR and VEGF in Patients With Advanced Non–small Cell Lung Cancer Harboring Activating EGFR Mutations: A Systematic Review and Meta-analysis : American Journal of Clinical Oncology

Secondary Logo

Journal Logo

Original Article

Efficacy and Toxicity of Combined Inhibition of EGFR and VEGF in Patients With Advanced Non–small Cell Lung Cancer Harboring Activating EGFR Mutations

A Systematic Review and Meta-analysis

Deluce, Jasna MD*; Maj, David MD*,†; Verma, Saurav MD*; Breadner, Daniel MD, MSc*; Boldt, Gabriel MScEd*; Raphael, Jacques MD, MSc*

Author Information
American Journal of Clinical Oncology ():10.1097/COC.0000000000000976, January 20, 2023. | DOI: 10.1097/COC.0000000000000976

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid